Literature DB >> 23238537

Contribution of TRPV1 receptor-expressing fibers to spinal ventral root after-discharges and mechanical hyperalgesia in a spared nerve injury (SNI) rat model.

Shohei Yamamoto1, Masahiro Ohsawa, Hideki Ono.   

Abstract

Neuropathic pain induces allodynia and hyperalgesia. In the spared nerve injury (SNI) model, marked mechanical hyperalgesia is manifested as prolongation of the duration of paw withdrawal after pin stimulation. We have previously reported that spinal ventral root discharges (after-discharges) after cessation of noxious mechanical stimulation applied to the corresponding hindpaw were prolonged in anesthetized spinalized rats. Since these after-discharges occurred through transient receptor potential (TRP) V1-positive fibers, these fibers could contribute to mechanical hyperalgesia. Therefore, we examined whether selective deletion of TRPV1-positive fibers by resiniferatoxin, an ultrapotent TRPV1 agonist, would affect the behavioral changes and ventral root discharges in SNI rats. Mechanical allodynia in the von Frey test, mechanical hyperalgesia after pin stimulation, and enhancement of ventral root discharges, but not thermal hyperalgesia in the plantar test, appeared in Wistar rats with SNI. Mechanical hyperalgesia was abolished by treatment with resiniferatoxin, whereas mechanical allodynia was not affected. Moreover, resiniferatoxin eliminated after-discharges completely. These results show that TRPV1-positive fibers do not participate in the mechanical allodynia caused by sensitization of Aβ-fibers, but contribute to the enhancement of after-discharges and mechanical hyperalgesia following SNI. It is suggested that the mechanisms responsible for generating mechanical allodynia differ from those for prolongation of mechanical hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238537     DOI: 10.1254/jphs.12213fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  6 in total

1.  Dexmedetomidine Increases the Latency of Thermal Antinociception in Rats.

Authors:  Yukako Tsutsui; Katsuhisa Sunada
Journal:  Anesth Prog       Date:  2017

2.  Loss of neurons in rostral ventromedial medulla that express neurokinin-1 receptors decreases the development of hyperalgesia.

Authors:  S G Khasabov; D A Simone
Journal:  Neuroscience       Date:  2013-07-03       Impact factor: 3.590

3.  (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.

Authors:  Aubin Moutal; Lindsey A Chew; Xiaofang Yang; Yue Wang; Seul Ki Yeon; Edwin Telemi; Seeneen Meroueh; Ki Duk Park; Raghuraman Shrinivasan; Kerry B Gilbraith; Chaoling Qu; Jennifer Y Xie; Amol Patwardhan; Todd W Vanderah; May Khanna; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2016-07       Impact factor: 7.926

4.  Targeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain.

Authors:  Jialie Luo; Edgar T Walters; Susan M Carlton; Hongzhen Hu
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

5.  Oxytocin-Dependent Regulation of TRPs Expression in Trigeminal Ganglion Neurons Attenuates Orofacial Neuropathic Pain Following Infraorbital Nerve Injury in Rats.

Authors:  Masatoshi Ando; Yoshinori Hayashi; Suzuro Hitomi; Ikuko Shibuta; Akihiko Furukawa; Tatsuki Oto; Takanobu Inada; Tomoyuki Matsui; Chikashi Fukaya; Noboru Noma; Masakazu Okubo; Yoshiyuki Yonehara; Tadayoshi Kaneko; Koichi Iwata; Masamichi Shinoda
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

6.  Genetic and functional evidence for gp130/IL6ST-induced transient receptor potential ankyrin 1 upregulation in uninjured but not injured neurons in a mouse model of neuropathic pain.

Authors:  Theodora Kalpachidou; Philipp Malsch; Yanmei Qi; Norbert Mair; Stephan Geley; Serena Quarta; Kai K Kummer; Michaela Kress
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.